ArticleAlzheimer's research & therapy2025

Dual risk of anticholinergic burden and CSF alzheimer's biomarkers in older patients: a mortality follow-up study from daily medical practice.

Théodore Decaix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.